This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in JAMA  Topic Collections  • Bacterial Infections  • Pulmonary Diseases  • Pneumonia  • Pulmonary Diseases, Other  • Quality of Care  • Quality of Care, Other  • Drug Therapy  • Drug Therapy, Other  • Infectious Diseases  • Alert me on articles by topic  Social Bookmarking   What's this?

A Step Closer to Tailored Care for Respiratory Infections?

Donald M. Yealy, MD; Michael J. Fine, MD, MSc

JAMA. 2009;302(10):1115-1116.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The advent of antibiotics led to dramatic reductions in mortality and medical complications from bacterial respiratory tract infections.¹ Although the armamentarium of diagnostic and therapeutic approaches has increased exponentially since that time, the effect of these advances on patient outcomes is less dramatic. Nevertheless, the goal of care remains constant: to match the patient's illness with a treatment approach that optimizes recovery while causing no harm. Harm exists in at least 2 forms: patient-specific, from an adverse event due to a diagnostic test or a treatment,² and population-based, from the development of bacterial resistance promoted by the misuse or overuse of antibiotics.^{1, 3}

Lower respiratory tract infections (LRTIs) are a pervasive public health problem and cause more disease and death in the United States than any other infection.⁴ Patients and their physicians share a goal of improving symptoms from LRTIs as quickly . . . [Full Text of this Article]

Author Affiliations: Department of Emergency Medicine, University of Pittsburgh School of Medicine (Dr Yealy); and Center for Health Equity Research and Promotion, VA Pittsburgh Healthcare System, and Division of General Internal Medicine, University of Pittsburgh Medical Center (Dr Fine), Pittsburgh, Pennsylvania.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

Effect of Procalcitonin-Based Guidelines vs Standard Guidelines on Antibiotic Use in Lower Respiratory Tract Infections: The ProHOSP Randomized Controlled Trial
Philipp Schuetz, Mirjam Christ-Crain, Robert Thomann, Claudine Falconnier, Marcel Wolbers, Isabelle Widmer, Stefanie Neidert, Thomas Fricker, Claudine Blum, Ursula Schild, Katharina Regez, Ronald Schoenenberger, Christoph Henzen, Thomas Bregenzer, Claus Hoess, Martin Krause, Heiner C. Bucher, Werner Zimmerli, Beat Mueller, and for the ProHOSP Study Group
JAMA. 2009;302(10):1059-1066.
ABSTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Procalcitonin Algorithm Reduces Antibiotic Use for Lower Respiratory Tract Infections
JWatch Emergency Med. 2009;2009:1-1.
FULL TEXT